Campbell Bradley L 4
4 · AMICUS THERAPEUTICS, INC. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-19$9.03/sh+400$3,612→ 1,151,057 total - Sale
Common Stock
2025-02-19$10.00/sh−400$4,000→ 1,150,657 total - Exercise/Conversion
Stock Options (right to buy)
2025-02-19−400→ 99,600 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (400 underlying)
Footnotes (1)
- [F1]All of the options were fully vested and exercisable as of the transaction date.